Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance

Homoharringtonine- (HHT-) based HHT, aclarubicin, and cytarabine (HAA) induction regimen is the first-line therapy for nonelder acute myeloid leukemia (AML) patients in China. However, drug resistance is a new challenge, and little attention has been devoted to excavating resistant mechanisms. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fenglin, Ling, Qing, Hu, Chao, Wang, Huafeng, Ye, Wenle, Li, Xia, Zhang, Xiang, Lin, Xiangjie, Wei, Wenwen, Huang, Xin, Qian, Yu, Zhuang, Haihui, Jin, Jie, Lu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448541/
https://www.ncbi.nlm.nih.gov/pubmed/36081671
http://dx.doi.org/10.1155/2022/2813938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448541/
https://www.ncbi.nlm.nih.gov/pubmed/36081671
http://dx.doi.org/10.1155/2022/2813938

Ejemplares similares